ACE2 and COVID-19: Accordingly, the present study aimed to assess the association of ACE2 expression and markers of oxidative stress, including malondialdehyde (MDA), total antioxidant capacity (TAC), and melatonin (MLT), with the clinical severity in patients with COVID-19.